“Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies”, Swiss Med Wkly, vol. 139, no. 0304, pp. 41–46, Jan. 2009, doi: 10.4414/smw.2009.12441.